Literature DB >> 4590238

The role of sulfhydryl groups in human neutrophil adhesion, movement and particle ingestion.

G F Giordano, M A Lichtman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4590238     DOI: 10.1002/jcp.1040820308

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


× No keyword cloud information.
  7 in total

1.  Effects of surface-active agents on neutrophil receptors.

Authors:  L A Boxer; S B Richardson; R L Baehner
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

2.  Dependence on the lipophilicity of maleimide derivatives in their inhibitory action upon chemotaxis in neutrophils.

Authors:  T Yamashita; Y Tanaka; T Horigome; E Fujikawa
Journal:  Experientia       Date:  1979-08-15

3.  The influence of some metabolic inhibitors on in vitro phagocytizing macrophages. I. The behaviour of human macrophages.

Authors:  C D'Onofrio; F Paradisi; D Piccolo
Journal:  Med Microbiol Immunol       Date:  1977-10-07       Impact factor: 3.402

4.  Free peripheral sulfhydryl groups, CD11/CD18 integrins, and calcium are required in the cadmium and nickel enhancement of human-polymorphonuclear leukocyte adherence.

Authors:  M Hernández; M Macia
Journal:  Arch Environ Contam Toxicol       Date:  1996-05       Impact factor: 2.804

5.  Antibody-dependent tumour cytolysis by human neutrophils: effect of synthetic serine esterase inhibitors and substrates.

Authors:  F Dallegri; G Frumento; A Ballestrero; R Goretti; A Torresin; F Patrone
Journal:  Immunology       Date:  1987-11       Impact factor: 7.397

6.  Modulation of the adherence of human polymorphonuclear leukocytes by cadmium and nickel: sexual differences.

Authors:  M Macia; M Hernández
Journal:  Arch Environ Contam Toxicol       Date:  1995-07       Impact factor: 2.804

7.  The effect of apomorphine on exocytosis and metabolic burst of polymorphonuclear leukocytes.

Authors:  J G Elferink
Journal:  Br J Pharmacol       Date:  1987-12       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.